BYSI
BYSI
NASDAQ · Biotechnology

Beyondspring Inc

$1.12
+0.34 (+44.11%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,828.6% upside
Low Target $29.80
Average Target $44.00
High Target $55.04
Current Price $1.12
Current
$1.12
Target
$44.00
$29.80 $44.00 avg $55.04
Scenario Analysis
Bear Case
$29.80
2,560.7%
Low target
Base Case
$44.00
+3,828.6%
Avg target
Bull Case
$55.04
+4,814.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.44
-54.1% from high
52-Week Low
$0.57
+98.0% from low
Target vs 52W High
$44.00
+1,703.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%